Tricyclodecan-9-yl-xanthogenate (D609) is an antioxidative molecule with antiproliferative and neuroprotective properties in a variety of cells. Previously, we have shown that D609 decreased the proliferation of neural progenitor cells. In this study, we examined the antioxidative property of D609 on neural progenitor cells isolated from the subventricular zone of the rat brain. Cellular oxidation was assessed by measuring the ATP content of the cells. Our results show that D609 decreased the ATP content of the neural progenitor cells by B40%, suggesting the possible inhibition of cellular metabolic activity. Cytochrome c oxidase (Cox), also known as complex IV of the electron transport chain, is a terminal enzyme involved in the oxidation of substrates resulting in the generation of energy required for the cellular activity. Therefore, regulating the activity of Cox could interfere with the generation of ATP, consequently affecting the proliferation of cells. Consistent with this hypothesis, we also observed a decrease in the Cox activity following the incubation of neural progenitor cells with D609. These results suggest that D609 could inhibit the activity of Cox and subsequent ATP synthesis in the neural progenitor cells. NeuroReport
Introduction
Tricyclodecan-9-yl-xanthogenate (D609) appears to be a multifunctional compound with an inhibitory effect on proliferation [1, 2] , inflammation [3] , and oxidation [4] [5] [6] in a variety of cells. Cellular oxidation of substrates produces energy in the form of ATP in the mitochondria. During this process, reactive oxygen species (ROS) are also generated, causing damage to proteins [7] , DNA [8] , and membrane phospholipids [9, 10] , thus playing a major role in cell death and disease process. However, the ROS are scavenged by the endogenous antioxidants, thereby preventing cell death.
D609 was originally discovered as a potent inhibitor of phosphatidylcholine-specific phospholipase C, which plays a major role in the survival and proliferation of cells [11, 12] . An earlier study has shown that D609 is a powerful antioxidant that behaves like a glutathione mimetic drug [13] . Similarly, there is abundant literature documenting the antiproliferative property of D609 in a variety of cells. We have shown that D609 can inhibit the proliferation of neural progenitor cells [14] . Despite several reports on D609-induced cell cycle arrest, the mechanism of action remains obscure. Moreover, very limited information is available on the antioxidative function of D609 on neural progenitor cells. Understanding the mechanism of D609 on its potential targets would enable us to harness its neuroprotective and antiproliferative properties as a therapy to treat pathological conditions such as stroke and cancer, both of which require ATP for survival and proliferation. In the present report, we investigated the antioxidative property of D609 by studying the cytochrome c oxidase (Cox) activity and ATP content of neural progenitor cells. These studies were carried out using an in-vitro cell culture model of neural progenitor cells isolated from adult rat brain.
Materials and methods

Materials
Adult male spontaneously hypertensive rats (250-350 g) were purchased from Charles River Laboratories (Portage, Michigan, USA). Neurobasal medium, B27 (without retinoic acid), recombinant human fibroblast growth factor-2 (FGF-2), and antibiotic mixture were purchased from Invitrogen (Carlsbad, California, USA). Other reagents were purchased from the following suppliers: CellTiter-Glow reagent (Promega Inc., Madison, Wisconsin, USA); cytochrome c oxidase kit, accutase, heparin, and glutamine were from Sigma Chemical Company (St Louis, Missouri, USA).
Cell culture
Neural progenitor cells were generated from the rat brain as described previously [15, 16] . All of the experimental procedures were performed in accordance with NIH Guidelines for the Care and Use of Laboratory Animals. Briefly, the animals were anesthetized using isoflurane and the subventricular zone tissue was carefully dissected from the brain. The subventricular zone tissue was minced and digested with papain, calpain, and dispase as described earlier [15, 16] . The dissociated cells were cultured in neurobasal medium containing B27, FGF-2 (20 ng/ml), glutamine (2 mM), antibiotics, and heparin (2 mg/ml) for 5-7 days and the resulting neurospheres were dissociated using accutase for further experiments. All the experiments were conducted between passages 3 and 20.
Reduction of MTS reagent by D609
MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)] is a tetrazolium salt that is converted into a formazan product upon reduction. Therefore, we examined the ability of D609 to reduce MTS into a formazan product by measuring its absorbance at 490 nm. D609 (0-25-50-100 mM) was added to culture medium containing B27 and FGF-2 in a 96-well plate. After 24 h of incubation, 20 ml of MTS reagent (CellTitre 96 AQ ueous ; Promega Inc.) was added to the medium, incubated at 371C for B2 h, and the absorbance was measured at 490 nm. The same volume of medium without D609 was used as a blank. Each individual experiment was repeated six times.
ATP measurement
The total ATP content was determined using the CellTitre-Glow assay kit (Promega Inc.) as described in the instruction manual. Neural progenitor cells (1 Â 10 4 / 50 ml) were cultured in an opaque 96-well microtiter plate for 24 h under various experimental conditions as described in the figure legends. At the end of the experimental period, the cells were equilibrated at room temperature for 30 min and mixed with an equal volume of CellTiter-Glow reagent (50 ml) on a shaker for 2 min, followed by continued incubation for another 10 min at room temperature. The luminescence generated by ATP was measured in a luminometer (Veritas; Turner Biosystems, Sunnyvale, California, USA) using the Promega Inc. protocol and expressed as relative light units (RLU). Each individual experiment was repeated 8-10 times in quadruplicate and represented as mean±SD.
Cox activity
Cox was measured using the cytochrome c oxidase assay kit (Sigma Chemical Company) according to the product instruction manual, with few modifications. The activity of Cox was measured by its ability to oxidize the reduced ferrocytochrome c and continuously monitoring the activity by measuring the absorbance at 550 nm for 1 min. Briefly, cells were homogenized in a buffer containing 20 mM Tris-HCl (pH 7.2), 0.25 M sucrose, 40 mM KCl, and 2 mM EGTA. The homogenate (100 mg/ 0.3 ml) containing Triton-X-100 (0.1% final concentration) was incubated on ice for 15 min before the enzyme assay. Total homogenate (25 mg) was used for the enzyme assay in the presence of reduced ferrocytochrome c as described in the manufacturer's protocol. Ferrocytochrome c was reduced using 0.1 M dithiothreitol (5 ml/ ml) for at least 15 min and its absorbance was measured at 550 and 565 nm before performing the assay. The reduced cytochrome c was used if the ratio of 550/565 was between 10 and 15 to ensure proper reduction of the compound. Each experiment was repeated 5-10 times and the activity of the enzyme was normalized to equal amounts of protein and expressed as U/ml.
Mitochondrial membrane potential
Neural progenitor cells were cultured on polyornithine/ laminin-coated coverslips in the presence or absence of D609 for 24 h. TMRE (tetramethylrhodamine, ethyl ester; final concentration 50 nM) was added to neural progenitor cells and incubated for 20 min to load mitochondria with dye. The cells were also stained with Hoechst (Sigma Chemical Company) to label the nucleus. At the end of incubation, images were captured using a Nikon fluorescence microscope (Nikon, Melville, New York, USA) at Â 20 magnification.
Statistical analysis
Data are represented as mean±SD of at least 5-10 individual experiments conducted in quadruplicate and analyzed using Student's t-test to compare two groups or analysis of variance supplemented by the Bonferroni post-hoc test for more than two groups. Values were considered significant at a P value of less than 0.05.
Results
Effect of D609 on MTS reagent
The antioxidative property of D609 was assessed by studying the ability of D609 to reduce the tetrazolium compound (MTS reagent) into a formazan product. Our results show that D609 reduced the MTS reagent as a function of concentration (Table 1) as shown by an increase in the absorbance at 490 nm.
Effect of D609 on the ATP content
We quantified the ATP content of the neural progenitor cells by measuring the luminescence produced because of the hydrolysis of ATP in a luciferin-luciferase-dependent reaction as RLU. The amount of light produced is proportional to the quantity of ATP present in the cells. Our results show that B27 (RLU = 24 44 731) increased the content of ATP (by B10-fold) in the neural progenitor cells as compared with the control (RLU = 2 22 037) or FGF-2 (RLU = 3 51 441)-treated cells, and there was no synergistic effect of FGF-2 on B27-induced ATP content (Fig. 1a ). Our results also show that D609 decreased (40%) the content of ATP in the neural progenitor cells cultured in complete medium (B27 + FGF-2) for 24 h (Fig. 1b ).
Effect of D609 on Cox activity
The addition of B27 to neural progenitor cells cultured in neurobasal medium considerably increased the activity of Cox, which is not significantly different when compared with cells supplemented with B27 + FGF-2 ( Fig. 2a ). However, D609 (100 mM) reduced the activity of Cox by B50% in the neural progenitor cells after a period of 24 h in culture (Fig. 2b ).
Effect of D609 on mitochondrial membrane potential
The proton gradient across the mitochondrial inner membrane is measured by adding the mitochondrial dye TMRE, which can enter the mitochondria, but will leak out in depolarized mitochondria, subsequently resulting in cell death. Our results show that 98% of cells retained the dye and there was no difference between the cells cultured in control and D609-treated cells (Fig. 3 ).
Discussion
Generally, the oxidation of substrates generates energy in the form of ATP and ROS as a byproduct. During the normal metabolic process, ROS are neutralized by endogenous antioxidative molecules such as glutathione, thereby maintaining the generation of energy while scavenging the ROS. However, during high oxygen demand, as observed during reperfusion following ischemia, the antioxidative mechanisms are unable to cope with the generation of ROS, resulting in enhanced cell death. Therefore, the use of antioxidative therapy during such a process can decrease the overproduction of ROS and reduce cell death. Similarly, in a normal cell, decreasing the substrate oxidation can result in the production of less ROS and ATP. A decrease in the ATP content can slow down the cellular process of proliferation, resulting in the arrest of cell cycle. Thus, antioxidative molecules seem promising for both neuroprotection and cancer because of their role in the metabolic process.
It appears that D609, being an antioxidative [5, 6] molecule, can decrease the oxidation and increase the reduction of substrates. Consistent with this hypothesis, our current data show that D609 increased the reduction of the MTS compound in a dose-dependent manner by converting the tetrazolium salt (MTS) into a formazan product, which is measured at 490 nm. Perhaps this could explain the increased reduction of MTS in our previous study [17] , prompting us to interpret an enhanced metabolic activity of the cells after one day in culture.
The reduction of MTS by D609 was observed after 24 h in culture, but not after 4 days, possibly because of the degradation of D609 in medium over time as reported by us recently [14] .
Our previous dose-response studies have shown a significant inhibitory effect of D609 on the proliferation of neural progenitor cells only at a 100 mM concentration, with no effect at a lower (5, 50 mM) concentration [17] . Therefore, we used 100 mM for all our experiments in this study to be consistent with our previous findings. Our current results show that D609 decreased the ATP content of the cells by B40%. One reason for the decreased ATP content could be an increased degradation or decreased synthesis of ATP by the neural progenitor cells. It is interesting to note that D609 inhibited the FGF-2-mediated proliferation [14] , but FGF-2 did not increase the ATP content; rather, B27 stimulated the synthesis of ATP in the neural progenitor cells (Fig. 2) . Majority of ATP is formed in the mitochondria during electron transport chain (ETC). Cox is a terminal enzyme in ETC that transfers electrons to a molecular oxygengenerating proton gradient, which is essential for the generation of ATP. Because D609 is an antioxidative molecule, we hypothesize it to inhibit the activity of Cox, which uses oxygen during the last step of ETC. Therefore, we measured the activity of Cox in cells treated with D609 and other growth supplements. Consistent with our ATP data, Cox activity was also upregulated (10-fold) in cells cultured in B27 as compared with the control and was not significantly different from B27 + FGF-2. Moreover, D609 inhibited the Cox activity of neural progenitor cells by B50%. These findings indicate that D609 might decrease the synthesis of ATP by inhibiting the activity of Cox. Our current results are in line with Control D609 (100 μM)
D609 did not alter the mitochondrial membrane potential. Neural progenitor cells were cultured on polyornithine/laminin-coated coverslips in the presence and absence of D609 (100 mM) for 24 h. At the end of the experimental period, TMRE and Hoechst were added to the cells to stain mitochondria and nuclei, respectively. TMRE staining was similar between control and D609-treated cells. Red, TMRE; blue, Hoechst (n = 3, scale bar = 50 mm).
previous observations showing the decreased synthesis of ATP following the inhibition of Cox [18, 19] .
The generation of ATP in the mitochondria is coupled to the proton gradient in the inner mitochondrial membrane during respiration. Growth factors play an important role in providing oxidizable substrates to the mitochondria, which produce a proton gradient across the mitochondrial membrane [20] . In agreement with this hypothesis, our study shows that neural progenitor cells cultured in growth medium produced a high ATP content. Therefore, we measured the mitochondrial membrane potential using TMRE dye and observed that D609 did not alter the mitochondrial membrane potential as detected by the lack of change in the TMRE staining. Data from these studies suggest that although the ATP content is decreased by B40% following D609 treatment, the proton gradient is maintained, keeping the cells viable. These results are consistent with our previous findings, which established that D609 (100 mM) did not induce cell death [14] after 24 h in culture.
Conclusion
Our results indicate that D609 can decrease the ATP content of neural progenitor cells by inhibiting the Cox-mediated generation of ATP in cells.
